Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

FRA/AN6 stock hub

FRA/AN6 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/AN6is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.7B

Frankfurt Stock Exchange

Market data

Price

Recent price action with selectable time range.

FRA/AN6FRA/AN6

—

Loading chart…

In the news

Latest news · FRA/AN6

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E197.3

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-24.5

P25 n/aP50 n/aP75 n/a

ROIC7.8

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/AN6 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

174

Groups with data

Currency

USD

Showing 174 of 174 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	DE
Employees	104
Employees Change	-32%
Employees Change Percent	-23.53
Enterprise value	EUR 1.7B
Exchange	Frankfurt Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-05-10
Market cap	EUR 1.7B
Price	EUR 58.3
Price currency	EUR
Rev Per Employee	1,921,263.22x
Sic	2836
Symbol	fra/AN6
Website	https://www.anaptysbio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-0.67%
EV Earnings	-148.67x
EV/EBIT	41.18x
EV/EBITDA	38.72x
EV/FCF	100.32x
EV/Sales	8.41x
FCF yield	0.99%
Forward P/E	197.35x
P/B ratio	53.43x
P/S ratio	8.47x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	20.42%
EBITDA Margin	20.65%
FCF margin	8.36%
Gross margin	42.04%
Gross Profit	EUR 84M
Gross Profit Growth Q	15,680.53%
Net Income	EUR -11.3M
Pretax Margin	-5.57%
Profit Margin	-5.64%
Profit Per Employee	EUR -108,362
ROA	7.06
Roa5y	-8.99
ROCE	14.7
ROE	-24.49
Roe5y	-71.52
ROIC	7.79

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	237.28%
Cagr3y	43.32%
Cagr5y	21.97%
Revenue Growth	157.02x
Revenue Growth Q	151.08x
Revenue Growth3 Y	183.58x
Revenue Growth5 Y	25.62x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.55
Assets	EUR 310.4M
Cash	EUR 265.4M
Current Assets	EUR 297M
Current Liabilities	EUR 32.8M
Debt	EUR 247.5M
Debt EBITDA	EUR 5.71
Debt Equity	EUR 7.81
Debt FCF	EUR 14.82
Equity	EUR 31.7M
Interest Coverage	0.6
Liabilities	EUR 278.7M
Long Term Assets	EUR 13.4M
Long Term Liabilities	EUR 245.9M
Net Cash	EUR 17.9M
Net Cash By Market Cap	EUR 1.06
Net Cash Growth	31.98%
Net Debt EBITDA	EUR -0.43
Net Debt Equity	EUR -0.56
Net Debt FCF	EUR -1.07
Tangible Book Value	EUR 31.7M
Tangible Book Value Per Share	EUR 1.13

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	9.07
Net Working Capital	EUR 1.8M
Quick ratio	8.94
Working Capital	EUR 265.4M
Working Capital Turnover	EUR 0.57

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-1.33%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	236.99%
200-day SMA	35.98
3Y total return	194.44%
50-day SMA	52.82
50-day SMA vs 200-day SMA	50over200
5Y total return	169.91%
All Time High	107.2
All Time High Change	-45.63%
All Time High Date	2018-02-20
All Time Low	8.96
All Time Low Change	550.38%
All Time Low Date	2019-11-08
ATR	3.18
Ch YTD	35.58
High	58.34
High52	60.58
High52 Date	2026-04-13
High52ch	-3.76%
Low	56
Low52	16
Low52 Date	2025-09-16
Low52ch	264.38%
Ma50ch	10.37%
Price vs 200-day SMA	62.04%
RSI	58.07
RSI Monthly	74.34
RSI Weekly	63.51
Sharpe ratio	1.97x
Sortino ratio	3.33
Total Return	-1.33%
Tr YTD	35.58
Tr1m	10%
Tr1w	-1.55%
Tr3m	38.81%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 40.8M
Operating margin	20.42

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	17,263,009%
Shares Insiders	2.93%
Shares Institutions	65.62%
Shares Qo Q	8.01%
Shares Yo Y	1.33%
Short Ratio	6.49

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -14M
Average Volume	5.05x
Bv Per Share	1.13
CAPEX	EUR -74,098
Ch1m	10
Ch1w	-1.55
Ch1y	237
Ch3m	38.81
Ch3y	194.4
Ch5y	169.9
Ch6m	71.47
Change	2.68%
Change From Open	3.15
Close	56.78
Days Gap	-0.46
Depreciation Amortization	474,010.8
Earnings Date	2026-05-15
EBIT	EUR 40.8M
EBITDA	EUR 41.3M
EPS	EUR -0.39
F Score	6
FCF	EUR 16.7M
FCF EV Yield	1x
Financing CF	-112,946,492
Fiscal Year End	December
Founded	2,005
Income Tax	EUR 139,679
Investing CF	194,214,854
Is Primary Listing	0
Last Earnings Date	2026-02-27
Last Report Date	2025-12-31
Ma150	41.69
Ma150ch	39.85%
Ma20	54.22
Ma20ch	7.53%
Net CF	98,044,297
Next Earnings Date	2026-05-15
Open	56.52
P FCF Ratio	101.4
P OCF Ratio	100.9
Position In Range	98.29
Ppne	11,777,344.2
Price Date	2026-05-08
Price EBITDA	EUR 41.03
Ptbv Ratio	53.43
Relative Volume	19.8x
Revenue	199,811,375x
SBC By Revenue	15.38x
Share Based Comp	30,722,522
Tax By Revenue	0.07x
Tr6m	71.47%
Volume	0
Z Score	0.46

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does FRA/AN6 pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/AN6 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/AN6?

Insider, institutional, and short-interest positioning.

Institutional ownership

+65.6%

Share of float held by funds and institutions

Insider ownership

+2.9%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

FRA/AN6 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

58.1

Neutral momentum band

Price vs 200-day MA

+62.0%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

1.97

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/AN6

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/AN6 stock rating?

fra/AN6 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/AN6 analysis?

The full report lives at /stocks/fra/AN6/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/AN6?

The latest report frames fra/AN6 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/AN6 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.